LexaGene Holdings Inc.
LXXGFOTCHealthcare
$0.08
+$0.00(+0.00%)
Market Cap$11335745
P/E Ratio—
52W High$0.2213
52W Low$0.04963
LexaGene Holdings Inc. (LXXGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LXXGF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-02 | 2021-02 | 2020-02 | 2019-02 | 2018-02 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.08M | $0.06M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.54M | $0.16M | $0.00M | $0.00M | $0.00M |
| Gross Profit | ($0.47M) | ($0.10M) | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | -621.40% | -173.76% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $5.88M | $5.81M | $4.46M | $5.38M | $1.67M |
| G&A Expenses | $3.02M | $2.83M | $1.31M | $1.57M | $1.73M |
| Total Operating Expenses | $10.10M | $9.71M | $7.40M | $8.32M | $3.98M |
| Operating Income | ($10.64M) | ($9.82M) | ($7.40M) | ($8.32M) | ($3.95M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.07M | $0.07M | $0.10M | $0.00M | $0.00M |
| Income Before Tax | ($10.62M) | ($9.89M) | ($7.50M) | ($8.32M) | ($4.00M) |
| Income Tax Expense | ($0.02M) | $0.07M | $0.10M | ($0.00M) | $0.03M |
| Net Income | ($10.62M) | ($9.97M) | ($7.60M) | ($8.32M) | ($4.03M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.09 | $-0.10 | $-0.10 | $-0.13 | $-0.08 |
| Wtd Avg Shares | 119.98M | 103.62M | 76.39M | 63.76M | 52.49M |
| EBITDA | ($10.05M) | ($9.29M) | ($6.89M) | ($8.19M) | ($3.93M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more LexaGene Holdings Inc. data
About LexaGene Holdings Inc. (LXXGF) Income Statement
LexaGene Holdings Inc. (LXXGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, LXXGF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -621.40%), and net income of ($0.01B) — a net profit margin of -14100.96%.
Frequently asked questions
LXXGF · 4 questionsLexaGene Holdings Inc. (LXXGF) reported revenue of $0.00B for 2022, up 29.6% year-over-year.
LXXGF revenueLXXGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09